ANEUVAS TECHNOLOGIES INC
Queen Creek, AZ · Medtech · Private
PPODA-QT, a novel biomaterial for endovascular embolization of cerebral aneurysms delivered via micro-catheter
- Grants
- $3.9M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Application of PPODA-QT for embolization of aneurysms | $220,109 | |
| Federal grant | Department of Health and Human Services · Phase I · Application of PPODA QT for embolization of aneurysms | $220,109 | |
| Federal grant | Department of Health and Human Services · Phase II · Application of PPODA-QT for embolization of aneurysms | $763,805 | |
| Federal grant | Department of Health and Human Services · Phase II · Application of PPODA-QT for embolization of aneurysms | $1,482,248 | |
| Federal grant | Department of Health and Human Services · Phase II · Application of PPODA-QT for embolization of aneurysms | $718,443 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing a new aspiration catheter solution for the treatment of large and medium vessel occlusions | $300,527 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing a new aspiration catheter solution for the treatment of large and medium vessel occlusions | $147,200 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1361 | BIODATA CONSORTIUM, LLC | — | — |
| 1362 | ROKHAN, LLC | — | — |
| 1363 | Noven, Inc. | — | $5.9M |
| 1364 | ANEUVAS TECHNOLOGIES INC | — | — |
| 1365 | PETL FLUIDICS LLC | — | — |
| 1366 | SIMX, INC | — | $1.1M |
| 1367 | AUTOMATED IMAGING DIAGNOSTICS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.